BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37249610)

  • 1. Association between bisphosphonate use and stroke risk: a meta-analysis.
    Lin SM; Lin JY; Tu YK; Wu CH; Peng CC; Munir KM; Bukhari K; Jaggon K; Fu Y; Loh CH; Huang HK
    Osteoporos Int; 2023 Sep; 34(9):1625-1636. PubMed ID: 37249610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates in multiple myeloma: an updated network meta-analysis.
    Mhaskar R; Kumar A; Miladinovic B; Djulbegovic B
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003188. PubMed ID: 29253322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
    Oh YH; Yoon C; Park SM
    World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
    Loke YK; Jeevanantham V; Singh S
    Drug Saf; 2009; 32(3):219-28. PubMed ID: 19338379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for steroid-induced osteoporosis.
    Allen CS; Yeung JH; Vandermeer B; Homik J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.
    Sharma A; Chatterjee S; Arbab-Zadeh A; Goyal S; Lichstein E; Ghosh J; Aikat S
    Chest; 2013 Oct; 144(4):1311-1322. PubMed ID: 23722644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.
    Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G
    Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis.
    Chen PW; Su HY; Tu YK; Wu CH; Yeh JI; Chen LY; Peng CC; Loh CH; Huang HK; Lin SM
    Osteoporos Int; 2023 Feb; 34(2):387-397. PubMed ID: 36464699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
    Mak A; Cheung MW; Ho RC; Cheak AA; Lau CS
    BMC Musculoskelet Disord; 2009 Sep; 10():113. PubMed ID: 19772579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for advanced prostate cancer.
    Macherey S; Monsef I; Jahn F; Jordan K; Yuen KK; Heidenreich A; Skoetz N
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006250. PubMed ID: 29278410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate use in children with cerebral palsy.
    Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
    Sun K; Liu JM; Sun HX; Lu N; Ning G
    Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.